Synapse

← Neuroprotection/Neuroprotection (Chichester, England. Print)

Papers in Neuroprotection/Neuroprotection (Chichester, England. Print)

Page 1 · newest first

  1. Celebrating 50 years of translational neuroscience in KuopioNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  2. Chronic high‐altitude exposure and intracerebral hemorrhage: A novel perspective from the vascular‐immune‐neuronal networkNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  3. Effectiveness and safety of efgartigimod in patients with anti‐NMDAR or anti‐LGI1 encephalitis and its 18 F‐DPA714 PET imaging evaluation: A multicenter, single‐arm, prospective, observational real‐world studyNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  4. Repurposing antimicrobial agents for neuroprotection: Mechanisms, clinical potential, and challengesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  5. Noninvasive or minimally invasive neuromodulation in animal models of acute ischemic stroke: A systematic review and meta‐analysisNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  6. Mesenchymal stem cells as cellular factories for targeted P2X7 blockade after traumatic brain injuryNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  7. Burden of ischemic stroke in China from 1990 to 2050: A systematic review and analysis of Global Burden of Disease Study 2021Neuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  8. Current status and future perspectives of platelet function‐guided precision antiplatelet therapy for patients with cerebral infarctionNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  9. Serum elemental profile‐based machine learning models for Alzheimer's disease identification and cognitive score predictionNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  10. Global trends in epilepsy and the Chinese experience: Epidemiological transitions, underlying mechanisms, and integrated strategies (1990–2021)Neuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  11. Graded traumatic brain injury severity differentially modulates microglial and astrocytic polarization states and response to minocyclineNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  12. Circadian rhythms and chronotherapy in Alzheimer's disease: Mechanisms and therapeutic implicationsNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  13. Post‐Omicron cognitive decline is largely reversible: Two‐year multicenter cohort study of domain‐specific outcomes in hospitalized patientsNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  14. Heparan sulfate and glycomimetics: Advances in synthesis and biological applications for post‐stroke neurorepairNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  15. An open‐source pipeline for longitudinal single‐cell tracking and cell‐cycle/migration coupling analysis for neurotherapeutic screeningNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  16. Imaging patterns and genetic associations of brain atrophy across distinct symptom stages in Parkinson's diseaseNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  17. Prime editing in neuropsychiatric disorders: From mutation‐specific target selection to clinical translationNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  18. Bee venom enhances dopaminergic function and behavioral recovery in a murine model of Parkinson's diseaseNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  19. Neuroprotective effects of ursodeoxycholic acid in Parkinson's disease and Alzheimer's diseaseNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  20. Post‐recanalization administration of rapamycin improves functional outcome and reduces infarct size in a rat model of ischemic strokeNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  21. Depletion of microglial compensation in glial network: Disease‐associated response dynamics in the revised amyloid hypothesisNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  22. Increased expression of aromatase after focal cerebral ischemia: Relevance to neuroprotection and functional recoveryNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  23. Comment on “Vitamin E for intraventricular hemorrhage prevention in preterm neonates: A systematic review and meta‐analysis”Neuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  24. New insights into disease‐modifying factors and clinical translation for central nervous system diseasesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  25. Exercise, exerkines, and muscle–brain crosstalk in Parkinson's diseaseNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  26. Research status and trends of Piezo1 and brain: A bibliometric analysisNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  27. Re‐conceptualizing Parkinson's disease as a lifelong neurobiological trajectory: A framework for preventionNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  28. Environmental enrichment modulates chronic poststroke inflammation and links white matter TREM2‐positive microglia in recovery in miceNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  29. Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disordersNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  30. Cerebral in situ ischemic postconditioning: From bench to bedside and beyondNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  31. Rehabilitation paired with vagus nerve stimulation for motor function of chronic ischemic stroke patients in China: Study protocol of a multicenter randomized controlled trial (Repair Study)Neuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  32. Regulatory B cells in the central nervous system: From immune regulation to neuroprotectionNeuroprotection/Neuroprotection (Chichester, England. Print) · 2026
  33. Spinal cord transection repair occurs when Nestin+ cells differentiate into neurons within a taxol‐collagen‐enhanced microenvironment in miceNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  34. A holistic view on disease‐modifying aspects, comorbidities, and contemporary neuroprotective approachesSHILAP Revista de lepidopterología · 2025
  35. Bibliometric analysis and core target identification of network pharmacology on neuroinflammation in central nervous system disorders: Trends, collaborations, and future directionsNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  36. Biological relationship between Parkinson's disease and gallstone diseaseNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  37. Therapeutic potential of stem cells in pediatric neurology: Insights from clinical trialsNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  38. Rapid eye movement sleep deprivation induced gene regulation for modulation of noradrenaline level in brain regions of rats: Implications with chronic sleep‐loss associated pathophysiological conditionsNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  39. Exploiting glial cell functions for neurodegeneration therapyNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  40. Acute hemichorea‐hemiballism as the initial sign of cortical cerebral infarction: A case reportNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  41. Efficient analysis of toxicity and mechanisms of isoflurane on postoperative delirium by network toxicology and molecular dockingNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  42. The effects and mechanisms of stem cells and exosomes on neurological function protection and recovery after ischemic strokeNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  43. Effects of senescence on astrocyte to brain endothelial cell signalingNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  44. Better understanding complex pathomechanisms in central nervous system disorders as a prerequisite for improved diagnostic and therapeutic approachesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  45. A comprehensive review on adaptive plasticity and recovery mechanisms post‐acquired brain injuryNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  46. Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic reviewNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  47. Beta cells to brain cells: The pivotal role of insulin and glucose metabolism in Alzheimer's diseaseNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  48. How pandemics reshape our brain: Common links and targets between long‐haul COVID‐19, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), oxidative stress, and neurodegenerationNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  49. Mitochondrial transfer as a novel therapeutic approach in ischemic stroke treatment: Current challenges and future perspectivesNeuroprotection/Neuroprotection (Chichester, England. Print) · 2025
  50. Vitamin E for intraventricular hemorrhage prevention in preterm neonates: A systematic review and meta‐analysisSHILAP Revista de lepidopterología · 2025